18,999 Followers on Owler


is an England-based pharmaceutical firm that develops and commercializes prescription medicines to the treatment of a range of diseases such as oncology and renal...
Read more

AstraZeneca Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue


AstraZeneca's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 40.9B. Over the last four quarters, AstraZeneca's revenue has decreased by 1%. Specifically, in Q2 2022's revenue was $10.8B; in Q3 2022, it was $11B; in Q4 2022, it was $11.3B; in Q1 2023, AstraZeneca's revenue was $10.9B.

AstraZeneca News

AstraZeneca Press Releases

AstraZeneca Videos

AstraZeneca Headquarters

1 Francis Crick Avenue Cambridge Biomedical Campus

Cambridge, EnglandCB2 0AA


Driving Directions »

AstraZeneca Summary



AstraZeneca UK Limited (LON: AZN) develops pharmaceutical solutions for cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. It discovers new medicines that are designed to improve the health and quality of ...


AstraZeneca's CEO, Pascal Soriot, currently has an approval rating of 81%. AstraZeneca's primary competitors are Pfizer, Novartis, GSK and 12 more.

Frequently Asked Questions about AstraZeneca

  1. When was AstraZeneca founded?

    AstraZeneca was founded in 1999
  2. Who is AstraZeneca's CEO?

    AstraZeneca's CEO is Pascal Soriot
  3. How much revenue does AstraZeneca generate?

    AstraZeneca generates $43.9B in revenue
  4. How much funding does AstraZeneca have?

    AstraZeneca has historically raised $100M in funding
  5. Where is AstraZeneca's headquarters?

    AstraZeneca's headquarters is in Cambridge England, GB
  1. How many employees does AstraZeneca have?

    AstraZeneca has 83,500 employees
  2. What sector does AstraZeneca operate in?

    AstraZeneca is in Pharmaceuticals
  3. Who are AstraZeneca's competitors?

    AstraZeneca's top competitors are Pfizer, Novartis, GSK
  4. Who has AstraZeneca invested in?

    AstraZeneca's has invested in companies such as AxBio, Silence Therapeutics, Innate Pharma

Trending Companies